Tender For supply of acamprosate gastro-resistant tablets , adapalene , adenine , bedaquiline fumarate , bepotastine besilate , calcium folinate tablets , calcium polystyrene sulphonate , cefprozil , dactinomycin or dactinomycin for injection , dapagliflozin or dapagliflozin and metformin hydrochloride prolonged-release tablets , dapagliflozin propanediol monohydrate , desloratadine or desloratadine tablets , entecavir oral solution , eribulin mesylate , eribulin mesylate or eribulin injection , etravirine or etravirine tablets , fulvestrant injection , low-substituted hydroxypropyl cellulose , iohexol or iohexol injection , micafungin sodium , minocycline hydrochloride or cap or inj or tab , morphine prolonged-release tablets , oxytocin concentrated solution , phytomenadione tablets , pilocarpine hydrochloride or pilocarpine hydrochloride eye drops , pilocarpine hydrochloride eye drops , pomalidomide or cap , proparacaine hydrochloride or proparacaine eye drops , acamprosate impurity a , acetylcysteine impurity a , acetylcysteine impurity b , acetylcysteine impurity c , acetylcysteine impurity d , adapalene impurity c , adapalene impurity a , adapalene impurity d , bedaquiline impurity b , bepotastine besilate r-isomer impurity , bepotastine impurity a , amoxycillin related compound i , cefprozil related compound d , celecoxib impurity a , celecoxib impurity b , clarithromycin identity , clindamycin impurity e , clindamycin impurity f , clindamycin impurity g , clindamycin impurity i , clindamycin impurity j , clindamycin impurity k , clindamycin impurity b , clindamycin impurity l , ortho isomer of dapagliflozin impurity , dapagliflozin dimer-1 , dapagliflozin impurity a , dapagliflozin impurity b , desloratadine related compound b , desloratadine related compound a , desloratadine related compound f , 5-chloro-2-methylaminobenzophenone , 3- amino-6-chloro-1-methyl-4-phenylquinolin-2-ol , eribulin impurity c , etravirine system suitability mixture , frusemide related compound b , fulvestrant impurity a , galantamine hydrobromide related compound mixture , iohexol related compound b , iohexol related compound a , iohexol related compound c , micafuin epimer , minocycline impurity a , minocycline impurity b , minocycline impurity c , minocycline impurity e , minocycline impurity f , minocycline impurity g , minocycline impurity h , morphine impurity f , pilocarpine impurity a , 3-amino-4- propoxybenzoic acid
Tender For supply of inj spikes for multidose vials minispikes - injection spikes for multidose vials minispikes , sodium valproate 100 mg per ml inj , phytomenadione 1 mg per 0 point 5 ml inj , phenytoin sodium 100 mg inj , succinylcholine chloride 50 mg per ml 2 ml inj , paracetamol 150 mg per ml 2 ml iv inj , paracetamol with cysteine hcl monohydrate infusion 1000 mg per 100 ml , tramadol hcl 50 mg per ml inj , inj thiamine 100 mg per ml , tranexamic acid 500 mg per 5 ml inj , vecuronium bromide 4 mg per ml 1 ml inj , inj vancomycin 500 mg , phenobarbitone sodium 200 mg 1 ml inj , promethazine hcl 2 point 5 percent 25 mg per ml 2 ml inj , hydroxyprogesterone caproate 500 mg per 2 ml inj , heparin 5000 iu per ml inj , ketamine hcl 50 mg per ml 2 ml inj , fentanyl citrate 50 mcg per ml 10 ml inj , hydrocortisone sodium succinate 100 mg inj , diazepam 10 mg 2 ml inj , adenosine 3 mg per ml 2 ml inj , dopamine hcl 40 mg per ml 5 ml inj , potassium chloride 15 percent inj amp of 10 ml , calcium 9 mg plus calcium gluconate 50 mg inj for iv use 10 ml inj , sodium bicarbonate 7 point 5 percent amp of 10 ml , esmolol 100 mg 10 ml inj , inj nitroglycerine 5 mg per ml , vasopressin 20 units per ml inj , pentazocine inj amp of 2 ml , haloperidol 5 mg per ml inj ) /bid number : gem/2025/b/6534101 * /dated: 04-08-2025 & & / bid document 1 / 25